Fumaric Acid

Fumaric Acid

SCHEMBL1463348

C=Cc1ccc(S(=O)(=O)O)cc1.O=C(O)C=CC(=O)O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 2/20 0.37
MEN1 known ✓ O00255 1/20 0.34
KMT2A known ✓ Q03164 1/20 0.34
TDP1 Q9NUW8 2/20 0.78
TSHR P16473 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 2/20 0.42
ALDH1A1 P00352 6/20 0.41
NT5E P21589 1/20 0.41
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 2/20 0.39
CYP2D6 P10635 1/20 0.39
PKM P14618 2/20 0.37
HCAR2 Q8TDS4 2/20 0.37
CA12 O43570 2/20 0.37
AKR1B10 O60218 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA3 P07451 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL1463346 1.00 TDP1 (0.78) TDP1TSHRSMN1; SMN2LMNAALDH1A1
Acrylic Acid SCHEMBL3406953 0.91 TDP1 (0.81) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL31126649 0.88 TDP1 (1.00) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL452529 0.88 TDP1 (1.00) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL25711 0.88 TDP1 (1.00) TDP1TSHRSMN1; SMN2LMNAALDH1A1
Acrylic Acid SCHEMBL28117148 0.87 TDP1 (0.75) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL331672 0.86 TDP1 (0.95) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL2121269 0.86 TDP1 (0.95) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL2198423 0.86 TDP1 (0.95) TDP1TSHRSMN1; SMN2LMNAALDH1A1
SCHEMBL17476625 0.86 TDP1 (0.95) TDP1TSHRSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480666-B1 COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL QIAGEN GAITHERSBURG INC (US) 2017-03-08 EP disclosed
US-9238809-B2 Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material QIAGEN GAITHERSBURG, INC. (US) 2016-01-19 US disclosed
EP-2480666-A1 COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL QIAGEN Gaithersburg, Inc. (US) 2012-08-01 EP disclosed
WO-2011037692-A1 COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL QIAGEN GAITHERSBURG INC. (US) 2011-03-31 WO disclosed
US-20110071031-A1 COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL QIAGEN GAITHERSBURG INC. (US) 2011-03-24 US disclosed